Sex and Gender: Hidden Keys to Smarter Cancer Care

The way we think about cancer has changed. Doctors now know that who you are and how you live can shape the disease in ways that were once ignored. Sex—defined by chromosomes, hormones and body parts—has a direct impact on how tumors grow, how the immune system fights them, and how patients feel after treatment. Gender—our roles, habits and social expectations—also matters because it influences diet, exercise, smoking habits and how often people visit a doctor. Most studies still treat everyone the same, ignoring these differences. This makes precision medicine less effective for many patients. Artificial intelligence (AI) offers a new path. By feeding it data that includes sex and gender, AI can spot hidden patterns in cancer biology. For example, algorithms can separate men from women with breast or prostate cancer and reveal distinct pathways that respond to specific drugs. The same idea works for lung cancer, where AI can identify which patients are likely to tolerate certain therapies.

The promise of AI is big, but it comes with hurdles. Data must be diverse and well labeled; otherwise the models learn wrong signals. Regulations also require that any AI tool used in clinics must protect patient privacy and avoid bias. Until these issues are solved, the technology risks widening existing gaps rather than closing them. To make AI truly useful for all patients, researchers need large, long‑term studies that include equal numbers of men and women. They also have to keep track of how gender roles change over time, because a person’s lifestyle can shift during treatment. When these steps are taken, AI can help doctors choose the best drug for each person, reduce side effects and improve overall survival. The bottom line is simple: sex and gender are powerful clues that can guide cancer treatment. Ignoring them means missing a chance to help patients live longer and healthier lives.

Actions